Chandra Adams - 01 Mar 2023 Form 4 Insider Report for Surface Oncology, Inc.

Role
Deputy GC
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 19:00:25 UTC
Previous filing
03 Nov 2022
Next filing
11 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 01 Mar 2023 Common Stock 50,000 $0.6900 Direct F1
transaction SURF Stock Option (Right to Buy) Award $0 +50,000 $0.000000 50,000 01 Mar 2023 Common Stock 50,000 $0.6900 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest in full on February 8, 2024, so long as the reporting person remains an employee or other service provider of the Issuer on such date.
F2 The Options shall vest in equal monthly installments over three years, so that all of the underlying shares shall be vested on February 8, 2026, so long as the reporting person remains an employee or other service provider of the Issuer on such dates.